WuXi Biologics and Aravive join forces on high-affinity bispecific antibodies

The collaboration will target cancer and fibrosis and use the WuXiBody Platform

picture of

Breaking News

Kitov Pharma receives notice for anti-CEACAM1 antibody patent

Kitov had applied for a European Patent Office entitled "Humanized antibodies against CEACAM1"

CordenPharma announces peptide manufacturing capacity expansion

The expansion has been planned to enable CordenPharma to manufacture a complex long peptide with a 400 kg output per ...

Omya completes expansion of Orgon production plant

State-of-the-art facility for sustainable, high-quality mineral products

Identifying nitrosamines in pharmaceutical products

The TEA detector has long been an industry standard for nitrosamine analysis in food and beverages, which can also be ...

Cambridge Uni spin-out raises $2.25m to transition to drug development

The 2016 spin-out PharmEnable's technology can predict improved small molecule hits to targets across a range of ...

Mission raises $15m and expands relationship with Pfizer

The new capital will support the development of Mission's deubiquitylating enzymes (DUB) platform, as well as growth of ...

Overcoming the excipient challenge with a multifunctional filler-binder

Dr Maj-Britt Cepok, Head of Business Development Pharma at BENEO, talks to Dr Kevin Robinson about trends in excipients ...

Sigrid Therapeutics obtains US patent for silica-based biomaterial SiPore15 for the treatment and prevention of obesity

Mesoporous silica particles (MSP) are a type of ingestible synthetic amorphous silica particles that can be produced ...

CPhI plans 'Pharma Festival' digital experience to replace postponed worldwide event

Informa have agreed with key partners to adapt to a digital format in 2020, a large-scale digital exhibition that will ...

Nitrosamines: Information for Marketing Authorisation Holders

Nitrosamine impurities have been in the regulatory spotlight since they were discovered in several blood pressure ...

How to comply with FDA-imposed nitrosamine impurity testing

The detection of nitrosamine impurities in commercially available drugs has recently prompted the US FDA to issue ...

The Lonza powder-in-capsule microdosing approach

Jeff Williamson and Ben Sahacic explain how microdosing offers a proven approach for biopharmaceutical companies to ...

DuPont achieves Non-GMO Certification for SeaGel

DuPont Nutrition & Biosciences’ latest certification will allow manufacturers to add the iconic non-GMO Project ...

Respira Technologies pursues API partnerships for new nebuliser

US-based Respira has launched pharmaceutical-focused commercial development platform for RespiRx medical device platform